VEGF secreted by cancer cells provides mitogenic and survival stimuli for endothelial cells, leading to the formation of new blood vessels, and in turn, tumor expansion.[26] In order to assess the inhibitory capability of the designed proteins, we tested their anti‐angiogenic effect on VEGF‐responsive primary human endothelial cells, HUVEC. This evidence concerns the gene VEGFA and cancer.